Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 74, Issue 6, 2006, Pages 347-356

  Alnajjar, A ^a   Chabane Sari, D ^a   Abuharfeil, N ^b   Hudaib, M ^c   Aburjai, T ^c  

^a UNIVERSITY OF TLEMCEN   (Algeria)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c UNIVERSITY OF JORDAN   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CONCANAVALIN A; DOCOSAHEXAENOIC ACID; EIOCOSAPENTAENOIC ACID; INSULIN; INTERLEUKIN 2; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; UNCLASSIFIED DRUG;

ADDITION REACTION; ADULT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; FATTY ACID ANALYSIS; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; JORDAN; LIPID COMPOSITION; LYMPHOCYTE MEMBRANE; LYMPHOCYTE PROLIFERATION; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ARACHIDONIC ACID; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; INSULIN; INTERLEUKINS; JORDAN; MALE; MEMBRANE LIPIDS; PHOSPHOLIPIDS; SUBCELLULAR FRACTIONS; T-LYMPHOCYTES;

EID: 33744524949     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.03.001     Document Type: Article

References (30)

1. Grimble R.F. Symposium on ''Evidence-based nutrition'' Nutritional modulation of immune function. Proc. Nutr. Soc. 60 (2001) 389-397
2. Pöschl. J.M.P., Paul. K., Leichsenring M., et al. Effects of dietary supplementation of saturated fatty acids and of n-6 or n-3 polyunsaturated fatty acids on plasma and red blood cell membrane phospholipids and deformability in Weanling Guinea pigs. Lipids 34 (1999) 467-473
3. Poisson J.-P.G., and Cunnane S. Long-chain fatty acid metabolism in fasting and diabetes: relation between altered desaturase activity and fatty acid composition. J. Nutr. Biochem. 2 (1991) 60-70
4. Harbige L.S. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc. Nutr. Soc. 57 (1998) 555-562
5. Calder PH.C. Effects of fatty acids and dietary lipids on cells of the immune system. Proc. Nutr. Soc. 55 (1996) 127-150
6. Horrocks L.A., and Yeo Y.K. Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40 (1999) 211-225
7. Freyburger G., Gin H., Heape A., Juguelin H., Boisseau M.R., and Cassagne C. Phospholipid and fatty acid composition of erythrocytes in type I and type II diabetes. Metabolism 38 (1989) 673-678
8. Berlin E., Bhathena S.J., Judd J.T., Nair P.P., Jones D.Y., and Taylor P.H.R. Dietary fat and hormonal effects on erythrocyte membrane fluidity and lipid composition in adult women. Metabolism 38 (1989) 790-796
9. Hughes D.A., Pinder A.C., Piper Z., and Lund E.K. N-3 polyunsaturated fatty acids (PUFA) modulate the expression of functionally associated molecules on human monocytes. Biochem. Soc. Trans. 23 (1995) 303S
10. McMurray D.N., Jolly C.H.A., and Chapkin R.S. Effects of dietary n-3 fatty acids on T cell activation and T cell receptor-mediated signaling in a murine model. J. Infect. Dis. 182 (2000) S103-S107
11. 2 as a mediator of cell shutdown. Immunology 42 (1981) 225-231
12. Watala C., and Jóźwiak Z. The phospholipids composition of erythrocyte ghosts and plasma lipoproteins in diabetes type 1 in children. Clin. Chim. Acta 188 (1990) 211-220
13. Driss F., Darcet P.H., Delhaye N., and Mendy F. Effect of eicosapentaenoic acid on red filterability and fatty acid composition. Clin. Hemorheol. 8 (1988) 679-685
14. Vidgren H.M., Agren J.J., Schwab U., Rissanen T., Hanninen O., and Uusitupa M.I.J. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32 (1997) 697-705
15. Igal A., and De Gómez Dumm N.T. Influence of dietary n-3 fatty acids on the biosynthesis of polyunsaturated fatty acids in STZ-diabetic rats. Nutr. Biochem. 6 (1995) 269-274
16. Salomaa V., Ahola J., Tuomilehto J., et al. Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism 39 (1990) 1285-1291
17. Kagi D., Ledermann B., Bürki K., Zinkernagel R.M., and Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14 (1996) 207-232
18. Decsi T., Minda. H., Hermann R., et al. Polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of diabetic children. Prostaglandins Leukot. Essent. Fatty Acids 67 (2002) 203-210
19. Brenner R.R. Hormonal modulation of Δ6 and Δ5 desaturases: case of diabetes. Prostaglandins Leukot. Essent. Fatty Acids 68 (2003) 151-162
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
21. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
22. Suresh Y., and Das U.N. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of ω-6 fatty acids. Nutrition 19 (2003) 93-114
23. Chang F.-Y., and Shaio M.-F. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diab. Res. Clin. Pract. 28 (1995) 137-146
24. Kaye W.A., Adri M.N.S., Soeldner J.S., et al. Acquired defect in interleukin-2 production in patients with type 1 diabetes mellitus. Engl. J. Med. 315 (1986) 920-924
25. Meydani S.N., Endres S., Woods M.M., et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J. Nutr. 121 (1991) 547-555
26. Calder P.C. Dietary fatty acids and the immune system. Lipids 34 (1999) S137-S140
27. Denys A., Hichami A., and Khan N.A. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Mol. Cell Biochem. 232 (2002) 143-148
28. Suresh Y., and Das U.N. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids 64 (2001) 37-52
29. Peterson L.D., Jeffery N.M., Thies F., Sanderson P., Newsholme E.A., and Calder P.C. Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 33 (1998) 171-180
30. Das U.N. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot. Essent. Fatty Acids 52 (1995) 387-391